BCL-2-话题@MedSci - 梅斯（MedSci）

#BCL-2#

29篇内容 | 1705人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1707320, encodeId=1f401e073204b, content=<a href='/topic/show?id=9948325e6d' target=_blank style='color:#2F92EE;'>#BCL-2#</a>, objectTitle=BCL-2抑制剂Venetoclax获NICE批准用于慢性淋巴细胞白血病, objectType=article, longId=158906, objectId=356b158906ea, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=356b158906ea, replyNumber=0, likeNumber=77, createdTime=2019-03-11, rootId=0, userName=ms3323097325231039, userId=e84031401266, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=356b158906ea, moduleTitle=BCL-2抑制剂Venetoclax获NICE批准用于慢性淋巴细胞白血病, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=356b158906ea)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1707316, encodeId=4fcc1e0731686, content=<a href='/topic/show?id=9948325e6d' target=_blank style='color:#2F92EE;'>#BCL-2#</a>, objectTitle=Eur J Pharmacol：Bcl-2抑制剂ABT-737在过敏性鼻炎模型中的抗过敏性和抗炎症作用研究, objectType=article, longId=140910, objectId=2bdb14091076, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2bdb14091076, replyNumber=0, likeNumber=71, createdTime=2019-04-30, rootId=0, userName=ms3323097325231039, userId=e84031401266, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2bdb14091076, moduleTitle=Eur J Pharmacol：Bcl-2抑制剂ABT-737在过敏性鼻炎模型中的抗过敏性和抗炎症作用研究, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=2bdb14091076)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1707319, encodeId=2aa81e07319e5, content=<a href='/topic/show?id=9948325e6d' target=_blank style='color:#2F92EE;'>#BCL-2#</a>, objectTitle=亚盛医药原创双靶点Bcl-2/Bcl-xL抑制剂APG-1252临床新数据亮相2018年亚洲肺癌大会（ACLC）, objectType=article, longId=153329, objectId=61c2153329d5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=61c2153329d5, replyNumber=0, likeNumber=62, createdTime=2019-06-21, rootId=0, userName=ms3323097325231039, userId=e84031401266, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=61c2153329d5, moduleTitle=亚盛医药原创双靶点Bcl-2/Bcl-xL抑制剂APG-1252临床新数据亮相2018年亚洲肺癌大会（ACLC）, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=61c2153329d5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1707317, encodeId=25931e07317a7, content=<a href='/topic/show?id=9948325e6d' target=_blank style='color:#2F92EE;'>#BCL-2#</a>, objectTitle=J Rheumatol：青少年皮肌炎血清可溶性细胞质Bcl-2蛋白水平升高, objectType=article, longId=146419, objectId=7a9f146419ff, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7a9f146419ff, replyNumber=0, likeNumber=59, createdTime=2019-03-13, rootId=0, userName=ms3323097325231039, userId=e84031401266, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7a9f146419ff, moduleTitle=J Rheumatol：青少年皮肌炎血清可溶性细胞质Bcl-2蛋白水平升高, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=7a9f146419ff)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1707315, encodeId=9e491e07315ed, content=<a href='/topic/show?id=9948325e6d' target=_blank style='color:#2F92EE;'>#BCL-2#</a>, objectTitle=Blood：Venetoclax，BCL-2抑制剂，用于idelalisib治疗中或治疗后的CLL患者的效果和安全性。, objectType=article, longId=125904, objectId=387a125904d3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=387a125904d3, replyNumber=0, likeNumber=64, createdTime=2018-03-12, rootId=0, userName=ms3323097325231039, userId=e84031401266, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=387a125904d3, moduleTitle=Blood：Venetoclax，BCL-2抑制剂，用于idelalisib治疗中或治疗后的CLL患者的效果和安全性。, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=387a125904d3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1707314, encodeId=2ba81e073149b, content=<a href='/topic/show?id=9948325e6d' target=_blank style='color:#2F92EE;'>#BCL-2#</a>, objectTitle=Blood：首次发现BCL-2抑制剂Venetoclax用于T幼淋巴细胞白血病患者可获得临床反应。, objectType=article, longId=114676, objectId=4ab01146e693, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4ab01146e693, replyNumber=0, likeNumber=72, createdTime=2018-03-25, rootId=0, userName=ms3323097325231039, userId=e84031401266, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4ab01146e693, moduleTitle=Blood：首次发现BCL-2抑制剂Venetoclax用于T幼淋巴细胞白血病患者可获得临床反应。, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=4ab01146e693)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1707312, encodeId=77201e073125b, content=<a href='/topic/show?id=9948325e6d' target=_blank style='color:#2F92EE;'>#BCL-2#</a>, objectTitle=Blood：以BCL-2为靶点治疗B细胞淋巴瘤的进展。, objectType=article, longId=106076, objectId=9f971060e6c7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9f971060e6c7, replyNumber=0, likeNumber=83, createdTime=2017-08-18, rootId=0, userName=ms3323097325231039, userId=e84031401266, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9f971060e6c7, moduleTitle=Blood：以BCL-2为靶点治疗B细胞淋巴瘤的进展。, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=9f971060e6c7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1707313, encodeId=cea21e0731325, content=<a href='/topic/show?id=9948325e6d' target=_blank style='color:#2F92EE;'>#BCL-2#</a>, objectTitle=Audiol Neurootol：miR-34a/Bcl-2信号通路能导致年龄相关听力损失中听觉神经细胞凋亡, objectType=article, longId=110928, objectId=55c111092861, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=55c111092861, replyNumber=0, likeNumber=85, createdTime=2018-01-06, rootId=0, userName=ms3323097325231039, userId=e84031401266, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=55c111092861, moduleTitle=Audiol Neurootol：miR-34a/Bcl-2信号通路能导致年龄相关听力损失中听觉神经细胞凋亡, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=55c111092861)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1707311, encodeId=66e61e073118d, content=<a href='/topic/show?id=9948325e6d' target=_blank style='color:#2F92EE;'>#BCL-2#</a>, objectTitle=Leukemia：选择性Bcl-2抑制剂ABT-199临床试验证明对白血病疗效良好, objectType=article, longId=27984, objectId=83392e98476, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=83392e98476, replyNumber=0, likeNumber=81, createdTime=2014-08-11, rootId=0, userName=ms3323097325231039, userId=e84031401266, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=83392e98476, moduleTitle=Leukemia：选择性Bcl-2抑制剂ABT-199临床试验证明对白血病疗效良好, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=83392e98476)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

BCL-2

2020-05-29

ms3323097325231039 (审核中...)

前往app查看评论内容

#BCL-2#

BCL-2抑制剂Venetoclax获NICE批准用于慢性淋巴细胞白血病

2019-03-11

ms3323097325231039 (审核中...)

前往app查看评论内容

#BCL-2#

Eur J Pharmacol：Bcl-2抑制剂ABT-737在过敏性鼻炎模型中的抗过敏性和抗炎症作用研究

2019-04-30

ms3323097325231039 (审核中...)

前往app查看评论内容

#BCL-2#

亚盛医药原创双靶点Bcl-2/Bcl-xL抑制剂APG-1252临床新数据亮相2018年亚洲肺癌大会（ACLC）

2019-06-21

ms3323097325231039 (审核中...)

前往app查看评论内容

#BCL-2#

J Rheumatol：青少年皮肌炎血清可溶性细胞质Bcl-2蛋白水平升高

2019-03-13

ms3323097325231039 (审核中...)

前往app查看评论内容

#BCL-2#

Blood：Venetoclax，BCL-2抑制剂，用于idelalisib治疗中或治疗后的CLL患者的效果和安全性。

2018-03-12

ms3323097325231039 (审核中...)

前往app查看评论内容

#BCL-2#

Blood：首次发现BCL-2抑制剂Venetoclax用于T幼淋巴细胞白血病患者可获得临床反应。

2018-03-25

ms3323097325231039 (审核中...)

前往app查看评论内容

#BCL-2#

Blood：以BCL-2为靶点治疗B细胞淋巴瘤的进展。

2017-08-18

ms3323097325231039 (审核中...)

前往app查看评论内容

#BCL-2#

Audiol Neurootol：miR-34a/Bcl-2信号通路能导致年龄相关听力损失中听觉神经细胞凋亡

2018-01-06

ms3323097325231039 (审核中...)

前往app查看评论内容

#BCL-2#

Leukemia：选择性Bcl-2抑制剂ABT-199临床试验证明对白血病疗效良好

2014-08-11

科室
- - 订阅+
  - 更多科室
工具
服务